These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 7685960)
1. Tenascin in inflammatory conditions and neoplasms of the urinary bladder. Tiitta O; Wahlström T; Virtanen I; Gould VE Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 63(5):283-7. PubMed ID: 7685960 [TBL] [Abstract][Full Text] [Related]
2. Distribution of tenascin in oral premalignant lesions and squamous cell carcinoma. Tiitta O; Happonen RP; Virtanen I; Luomanen M J Oral Pathol Med; 1994 Nov; 23(10):446-50. PubMed ID: 7532219 [TBL] [Abstract][Full Text] [Related]
3. Tenascin expression in inflammatory, dysplastic and neoplastic lesions of the human stomach. Tiitta O; Sipponen P; Gould V; Virtanen I Virchows Arch; 1994; 425(4):369-74. PubMed ID: 7529617 [TBL] [Abstract][Full Text] [Related]
4. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. Howeedy AA; Virtanen I; Laitinen L; Gould NS; Koukoulis GK; Gould VE Lab Invest; 1990 Dec; 63(6):798-806. PubMed ID: 1701508 [TBL] [Abstract][Full Text] [Related]
5. Enhanced tenascin expression in cervical and vulvar koilocytotic lesions. Tiitta O; Wahlström T; Paavonen J; Linnala A; Sharma S; Gould VE; Virtanen I Am J Pathol; 1992 Oct; 141(4):907-13. PubMed ID: 1384340 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder. Berndt A; Anger K; Richter P; Borsi L; Brack S; Silacci M; Franz M; Wunderlich H; Gajda M; Zardi L; Neri D; Kosmehl H J Cancer Res Clin Oncol; 2006 Aug; 132(8):537-46. PubMed ID: 16788848 [TBL] [Abstract][Full Text] [Related]
7. Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast. Koukoulis GK; Howeedy AA; Korhonen M; Virtanen I; Gould VE J Submicrosc Cytol Pathol; 1993 Apr; 25(2):285-95. PubMed ID: 7686813 [TBL] [Abstract][Full Text] [Related]
8. Towards defining roles and relationships for tenascin-C and TGFbeta-1 in the normal and neoplastic urinary bladder. Booth C; Harnden P; Selby PJ; Southgate J J Pathol; 2002 Nov; 198(3):359-68. PubMed ID: 12375269 [TBL] [Abstract][Full Text] [Related]
9. Comparison of distributions of survivin among tissues from urinary bladders of dogs with cystitis, transitional cell carcinoma, or histologically normal urinary bladders. Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Green JA Am J Vet Res; 2008 Aug; 69(8):1073-8. PubMed ID: 18672973 [TBL] [Abstract][Full Text] [Related]
10. Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder. Chang S; Lee S; Lee C; Kim JI; Kim Y Urology; 2000 Mar; 55(3):448-52. PubMed ID: 10699635 [TBL] [Abstract][Full Text] [Related]
11. Enhanced tenascin immunoreactivity in leukoplakia and squamous cell carcinoma of the oral cavity: an immunohistochemical study. Shrestha P; Sakamoto F; Takagi H; Yamada T; Mori M Eur J Cancer B Oral Oncol; 1994; 30B(2):132-7. PubMed ID: 7518275 [TBL] [Abstract][Full Text] [Related]
12. Basement membrane and extracellular interstitial matrix components in bladder neoplasia--evidence of angiogenesis. Deen S; Ball RY Histopathology; 1994 Nov; 25(5):475-81. PubMed ID: 7532615 [TBL] [Abstract][Full Text] [Related]
13. Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma. Vinall RL; Kent MS; deVere White RW Am J Vet Res; 2012 Oct; 73(10):1626-33. PubMed ID: 23013190 [TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix proteins and their receptors in the normal, hyperplastic and neoplastic breast. Gould VE; Koukoulis GK; Virtanen I Cell Differ Dev; 1990 Dec; 32(3):409-16. PubMed ID: 1711920 [TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues. Natali PG; Nicotra MR; Bigotti A; Botti C; Castellani P; Risso AM; Zardi L Int J Cancer; 1991 Apr; 47(6):811-6. PubMed ID: 1707033 [TBL] [Abstract][Full Text] [Related]
16. Tenascin expression in astrocytomas correlates with angiogenesis. Zagzag D; Friedlander DR; Miller DC; Dosik J; Cangiarella J; Kostianovsky M; Cohen H; Grumet M; Greco MA Cancer Res; 1995 Feb; 55(4):907-14. PubMed ID: 7531617 [TBL] [Abstract][Full Text] [Related]
17. Localization of tenascin in uterine sarcomas and partially transformed endometrial stromal cells. Vollmer G; Lightner VA; Carter CA; Siegal GP; Erickson HP; Knuppen R; Kaufman DG Pathobiology; 1993; 61(2):67-76. PubMed ID: 7692874 [TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer. Moch H; Torhorst J; Dürmüller U; Feichter GE; Sauter G; Gudat F Pathol Res Pract; 1993 Jun; 189(5):510-4. PubMed ID: 7690952 [TBL] [Abstract][Full Text] [Related]
19. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078 [TBL] [Abstract][Full Text] [Related]
20. [Expression of extracellular matrix (tenascin) in the gastric cancer--an immunohistochemical study]. Yano S Nihon Geka Gakkai Zasshi; 1993 Oct; 94(10):1085-91. PubMed ID: 7694065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]